The Rx Research Corner is a blog written by the Research Team at PCMA. This blog will take a closer look at complex data and new research findings. Topics cover the PBM and prescription drug space and range from pricing, to policies, and to patient issues such as access and equity.
Inclusion vs. Exclusion from the IRA Medicare Direct Negotiation Drug List: When “Small” Doesn’t Really Mean Small
A data-driven look at the Medicare Part B and Part D drugs that might qualify for the “small biotech” exemption from drug price negotiation in the Inflation Reduction Act.
The PBM Marketplace is More Competitive, Not Less
In just two years, six new pharmacy benefit companies entered the marketplace, an almost nine percent increase. Today there are 73 full-service PBMs in operation. This demonstrates that the marketplace is not only diverse but becoming more competitive over time.
Pharmacy Benefit Companies 101: A Primer
Given all the recent attention around pharmacy benefit companies and prescription drug costs, I thought it would be helpful to create a primer of what exactly a pharmacy benefit company is and does.
The Independent Pharmacy Marketplace is Still Stable
Recent small fluctuations year-to-year in the number of independent pharmacies has not dramatically shifted the independent pharmacy market and continues to foster a stable market.
Setting the Record Straight on Patient Cost Sharing
It seems that some have been tossing around the word fact lately when they really mean opinion. Facts are things that we have real evidence
The Ghosts of Biosimilars: The Past, the Present, and the Future
With a nod to Dickens given that it’s the holidays, I’ve been thinking about biosimilars past, present and future lately. In that holiday spirit, even
